News - Page 255 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Champignon Provides Update on Disclosure Review

Champignon Provides Update on Disclosure Review

Post published:September 15, 2020
Post category:Press Release

Read more about the article Mydecine Innovations Group, Inc. to Create Special Committee for the Spin Out of US Related Assets

Mydecine Innovations Group, Inc. to Create Special Committee for the Spin Out of US Related Assets

Post published:September 15, 2020
Post category:Press Release

Read more about the article Thoughtful Brands Reports August, July and June 2020 Revenue Totaling of CDN$8,861,000 for Nature’s Exclusive Representing a 19% Increase over the same Period in 2019

Thoughtful Brands Reports August, July and June 2020 Revenue Totaling of CDN$8,861,000 for Nature’s Exclusive Representing a 19% Increase over the same Period in 2019

Post published:September 15, 2020
Post category:Financials Press Release

Read more about the article GreenStar Biosciences Announces New Provisional Patent Application

GreenStar Biosciences Announces New Provisional Patent Application

Post published:September 14, 2020
Post category:Press Release

Read more about the article Hollister Biosciences Retains Renmark Financial Communications Inc.

Hollister Biosciences Retains Renmark Financial Communications Inc.

Post published:September 11, 2020
Post category:Press Release

Read more about the article Dr. Bronner’s ‘Heal Soul’ Campaign Educates Public on Psychedelics, Donates Over $3m to Psychedelic Therapy Efforts in 2020 Alone

Dr. Bronner’s ‘Heal Soul’ Campaign Educates Public on Psychedelics, Donates Over $3m to Psychedelic Therapy Efforts in 2020 Alone

Post published:September 11, 2020
Post category:News

Read more about the article Numinus Announces Closing of Oversubscribed $4.6 Million Offering

Numinus Announces Closing of Oversubscribed $4.6 Million Offering

Post published:September 10, 2020
Post category:Press Release

Read more about the article Havn Life Sciences Granted Section 56 Exemption to Begin Scientific Work With Psilocybin

Havn Life Sciences Granted Section 56 Exemption to Begin Scientific Work With Psilocybin

Post published:September 10, 2020
Post category:Press Release

Read more about the article Will Australia be the First Country to Reap the Benefits of Psychedelic Medicines? Rescheduling Proposal Submitted to TGA

Will Australia be the First Country to Reap the Benefits of Psychedelic Medicines? Rescheduling Proposal Submitted to TGA

Post published:September 10, 2020
Post category:News

Read more about the article Psychedelics Company Havn Life Announces Commencement of Public Trading on the CSE

Psychedelics Company Havn Life Announces Commencement of Public Trading on the CSE

Post published:September 8, 2020
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.